TY - JOUR
T1 - ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations
AU - Cserni, Bálint
AU - Kilmartin, Darren
AU - O’Loughlin, Mark
AU - Andreu, Xavier
AU - Bagó-Horváth, Zsuzsanna
AU - Bianchi, Simonetta
AU - Chmielik, Ewa
AU - Figueiredo, Paulo
AU - Floris, Giuseppe
AU - Foschini, Maria Pia
AU - Kovács, Anikó
AU - Heikkilä, Päivi
AU - Kulka, Janina
AU - Laenkholm, Anne Vibeke
AU - Liepniece-Karele, Inta
AU - Marchiò, Caterina
AU - Provenzano, Elena
AU - Regitnig, Peter
AU - Reiner, Angelika
AU - Ryška, Aleš
AU - Sapino, Anna
AU - Stovgaard, Elisabeth Specht
AU - Quinn, Cecily
AU - Zolota, Vasiliki
AU - Webber, Mark
AU - Glynn, Sharon A.
AU - Bori, Rita
AU - Csörgő, Erika
AU - Oláh-Németh, Orsolya
AU - Pancsa, Tamás
AU - Sejben, Anita
AU - Sejben, István
AU - Vörös, András
AU - Zombori, Tamás
AU - Nyári, Tibor
AU - Callagy, Grace
AU - Cserni, Gábor
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/2
Y1 - 2023/2
N2 - Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2–11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.
AB - Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2–11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.
KW - breast cancer
KW - European Working Group for Breast Screening Pathology
KW - international immuno-oncology biomarker working group
KW - observers needed to evaluate subjective tests
KW - ONEST
KW - reproducibility
KW - sTILs
KW - TILs
KW - triple-negative
KW - tumour-infiltrating lymphocytes
UR - http://www.scopus.com/inward/record.url?scp=85149152852&partnerID=8YFLogxK
U2 - 10.3390/cancers15041199
DO - 10.3390/cancers15041199
M3 - Journal article
C2 - 36831541
AN - SCOPUS:85149152852
SN - 2072-6694
VL - 15
JO - Cancers
JF - Cancers
IS - 4
M1 - 1199
ER -